Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,263 public trials 689 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Recruiting

SLV-154 Treatment of Advanced Cancers

NCT06771219

Conditions
Advanced Cancer, Advanced Solid Tumor, Metastatic Cancer, +5 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Washington University St Louis, Missouri, United States
  • Astera Cancer Care East Brunswick, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

NCT05372614

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +15 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
View all 18 locations
View Trial Details
Recruiting

IDOV-Immune for Advanced Solid Tumors

NCT06910657

Conditions
Adenocarcinoma, Adnexal Diseases, Adrenal Gland Diseases, +94 more
Locations
  • Washington University School of Medicine St Louis, Missouri, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • South Texas Accelerated Research Therapeutics San Antonio, Texas, United States
  • Westmead Hospital Westmead, New South Wales, Australia
View Trial Details
Recruiting

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

NCT07277413

Conditions
Adenocarcinoma Of Esophagus, Adenocarcinoma of Esophagus, Adenoma, +55 more
Locations
  • Providence Medical Foundation Santa Rosa, California, United States
  • Johns Hopkins Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • BRCR Global-Coral Springs Coral Springs, Florida, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
View all 16 locations
View Trial Details
Recruiting

A Study of ASP1002 in Adults for Treatment of Solid Tumors

NCT05719558

Conditions
Advanced Solid Tumors, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • Yale University Cancer Center New Haven, Connecticut, United States
  • Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut Plainville, Connecticut, United States
  • University of Florida Gainesville, Florida, United States
  • University of Iowa Hospitals Iowa City, Iowa, United States
View all 15 locations
View Trial Details
Recruiting

Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors

NCT03934372

Conditions
Accelerated Phase Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, +31 more
Locations
  • Ghent University Hospital Ghent, Belgium
  • Hopital Robert Debre Paris, France
  • Armand Trousseau Hospital Paris, France
  • Centre Hospitalier Universitaire de Poitiers Poitiers, France
View all 23 locations
View Trial Details

Related conditions